David Rostov

Chief Financial Officer at LogicGate
Greater Seattle Area

David Rostov is Chief Financial Officer at LogicGate. He has served as CFO of Aurion Biotech, CorneaGen, Identity Digital and Avalara, scaling biotech and technology companies through fundraising, M&A and successful exits. He has been a board member in public companies, private companies and not-for-profit organizations.

Aurion Biotech Raises $120M to Advance Cell Therapy for Corneal Edema Affecting Millions

Aurion Biotech, a spinoff of CorneaGen, has raised $120 million to advance its cell therapy for treating corneal edema caused by endothelial dysfunction, a condition leading to impaired vision or blindness affecting about 4% of people over 40 in the U.S. The therapy uses cultured corneal cells from a single donor to treat multiple patients with a less complex procedure than corneal transplantation.

Smartsheet CFO Jennifer Ceran joins Auth0 board; Auth0 hires three execs; Outreach opens NYC office led by David Rubinstein

Smartsheet CFO Jennifer Ceran joined the board of Bellevue identity provider Auth0 as she prepares to retire, and Auth0 added three senior hires: Holly Files (SVP customer success), Cassio Sampaio (VP product) and Ken Oestreich (VP product marketing). Separately, Seattle sales-engagement firm Outreach is opening a New York City office led by David Rubinstein as part of its U.S. and international expansion.

Organizations

See all 5
  • LogicGate Chief Financial Officer 2026–present · current
  • Aurion Biotech logo
    Aurion Biotech Executive Officer 2022–2024, Chief Financial Officer 2021–2024 · past
  • CorneaGen Chief Financial Officer 2020–2022 · past

Education

  • The University of Chicago Booth School of Business MBA, Finance, General
  • University of Chicago MA, Public Policy

Online